Redmile Group, LLC - Jul 2, 2025 SCHEDULE 13D/A Report for FATE THERAPEUTICS INC Common Stock, par value $0.001 per share (FATE)

Filing Manager
Redmile Group, LLC
Reporting Manager
Redmile Group, LLC
Security
FATE THERAPEUTICS INC Common Stock, par value $0.001 per share
Symbol
FATE
Shares outstanding
120M shares
Disclosed Ownership
17.9M shares
Ownership
14.9%
Form type
SCHEDULE 13D/A
Date filed
7/3/2025, 04:01 PM
Date of event
Jul 2, 2025
Previous filing
Dec 26, 2024
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Redmile Group, LLC 14.9% 17.9M 0 17.9M /s/ Jeremy C. Green Managing Member 0001425738
Jeremy C. Green 14.9% 17.9M 0 17.9M /s/ Jeremy C. Green Jeremy C. Green 0001650527
RedCo II Master Fund, L.P. 11.3% 13.5M 0 13.5M /s/ Jeremy C. Green Managing Member of RedCo II (GP), LLC, its General Partner 0001921783